Despite its advancements, oral semaglutide does exhibit some limitations
consider ECG if clinically indicated Nutritional status : Assess current dietary intake, eating patterns, and screen for disordered eating behaviours Mental health evaluation : Screen for depression, anxiety, or other psychiatric comorbidities that may affect treatment adherence or outcomes Weight and metabolic parameters : Record baseline weight, BMI, waist circumference, and relevant blood tests (HbA1c, lipid profile, renal function) Pregnancy status : Exclude pregnancy and discuss contraception requirements (Wegovy is contraindicated in pregnancy) Treatment should begin with a dose of 0.25 mg once weekly, increasing every 4 weeks (0.5 mg, 1.0 mg, 1.7 mg) to reach the maintenance dose of 2.4 mg if tolerated
Data was acquired in a data-dependent acquisition mode, and the resulting spectra were processed and searched against the UniProt database using the MaxQuant software
An industry group representing compounders is suing
TFR1 (1:1000, ABclonal, A5865)
doi: 10.1016/S0140-6736(10)60307-8